|
Sharon E. Tetlow joined Cell Genesys in June 2005 and serves as Cell Genesys' senior vice president and chief financial officer. Prior to joining Cell Genesys, Ms. Tetlow was a venture partner at Apax Partners and brings over 18 years of financial management experience in the life science industry, including the last five years as chief financial officer at diaDexus, Inc. Ms. Tetlow was also chief financial officer at Reprogen, Inc. and Terrapin Technologies (now Telik). She also held senior finance positions at Synergen, Inc. (now part of Amgen, Inc.) and Genentech, Inc. Earlier in her career, Ms. Tetlow was an associate at the Brookings Institution in Washington, D.C. Ms. Tetlow holds a Master of Business Administration from the Graduate School of Business, Stanford University, and a Bachelor of Arts and Science degree magna cum laude, from the University of Delaware. | 